During Wednesday’s Current trade, Shares of Molina Healthcare, Inc. (NYSE:MOH), gain 2.59% to $68.45.
Molina Healthcare, Inc. (MOH) declared that it will report its earnings for the third quarter and nine months ended September 30, 2015, after the market closes on Thursday, October 29, 2015. The Company’s administration will host a conference call and webcast to talk about the earnings release at 5:00 p.m. Eastern time on the same day.
Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program.
Shares of Juno Therapeutics Inc (NASDAQ:JUNO), inclined 1.63% to $40.54, during its current trading session.
Juno Therapeutics, Inc. (JUNO) declared that it will webcast its presentation at the 2015 Leerink Partners Immuno-Oncology Roundtable at 8:25 a.m. ET on Thursday, October 1, 2015. The presentation will feature a business overview and update by Steve Harr, Juno’s Chief Financial Officer and Head of Corporate Development.
Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.
Automatic Data Processing (NASDAQ:ADP), during its Wednesday’s current trading session gained 0.82% to $79.74.
ADP(R) (ADP), a leading global provider of Human Capital Administration (HCM) solutions, is planned to release its financial results for the first quarter fiscal ending September 30, 2015 before the opening of the Nasdaq on Wednesday, October 28, 2015.
Automatic Data Processing, Inc., together with its auxiliaries, provides business process outsourcing services worldwide. The company operates through two segments, Employer Services and Professional Employer Organization (PEO) Services.
Finally, DaVita HealthCare Partners Inc (NYSE:DVA), gained 1.57%, to $72.27.
DaVita HealthCare Partners Inc. (DVA), a leading global provider of kidney care services and a leading independent medical group in the United States, declared plans to start operations in Brazil. The company, which operates in 11 countries serving more than 1.5 million patients, aims to bring its global expertise and leading clinical outcomes to the country.
DaVita plans to assist Brazilian physicians grow their practice by providing them access to a worldwide network of experts, best-in-class training programs and the most advanced clinical and administrative service standards.
There are more than 110,000 Brazilians on dialysis, a number that many studies suggest is on the rise due to the increasing prevalence of chronic kidney disease in the country.
DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
